Gross Margin
12.77%vs Specialty Chemicals peers Updated Aug 19, 2026Profit Margin
-1.75%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Margin
1.63%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Assets (TTM)
0.12%vs Specialty Chemicals peers Updated Aug 19, 2026Return on Equity (TTM)
-1.04%vs Specialty Chemicals peers Updated Aug 19, 2026Revenue (TTM)
945.33MCNY140.40M · vs all stocks (USD) Updated Aug 19, 2026Revenue per Share (TTM)
3.67CNYUpdated Aug 19, 2026Quarterly Revenue Growth
9.20%vs Specialty Chemicals peers Updated Aug 19, 2026Gross Profit (TTM)
119.72MCNY17.78M · vs all stocks (USD) Updated Aug 19, 2026EBITDA (TTM)
97.13MCNY14.43M · vs all stocks (USD) Updated Aug 19, 2026Net Income (TTM)
-16.57MCNY-2.46M · vs all stocks (USD) Updated Aug 19, 2026Quarterly Earnings Growth (YoY)
2.18%vs Specialty Chemicals peers Updated Aug 19, 2026Operating Cash Flow (TTM)
125.64MCNY18.66M · vs all stocks (USD) Updated Aug 19, 2026Levered Free Cash Flow (TTM)
35.15MCNY5.22M · vs all stocks (USD) Updated Aug 19, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Aug 19, 2026Minority Interest (Equity)
14.77MCNYFY2025 · Dec 31, 2025Revenue
868.79MCNYFY2025 · Dec 31, 2025Cost of Goods Sold
776.20MCNYFY2025 · Dec 31, 2025Gross Profit
92.59MCNYFY2025 · Dec 31, 2025Operating Income
1.32MCNY195.65K · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-42.34MCNYFY2025 · Dec 31, 2025Income Tax Expense
-3.66MCNYFY2025 · Dec 31, 2025Net Income
-38.68MCNYFY2025 · Dec 31, 2025EBIT
-26.66MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
97.13MCNYFY2025 · Dec 31, 2025Research & Development
8.93MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
27.26MCNYFY2025 · Dec 31, 2025Other Operating Expenses
9.83MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
6.90MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
15.69MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1555CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1555CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
260.94MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
260.94MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-38.68MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-1.89MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
40.67MCNYFY2025 · Dec 31, 2025Free Cash Flow
30.90MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
296.70MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-38.68MCNYFY2025 · Dec 31, 2025Other Non-cash Items
18.99MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
80.63MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-20.27MCNYFY2025 · Dec 31, 2025Capital Expenditures
-9.76MCNYFY2025 · Dec 31, 2025Purchase of Investments
-10.60MCNYFY2025 · Dec 31, 2025Sale of Investments
1.50KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-20.36MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
114.90MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-226.21MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-13.05MCNYFY2025 · Dec 31, 2025Other Financing Charges
57.01MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-67.35MCNYFY2025 · Dec 31, 2025